Explore more publications!
Oman Technology Reporter
Got News to Share?

Oman Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Technology Reporter.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 24, 2025

Cerence Announces Repurchase of $30 Million of 1.50% Convertible Senior Notes Due 2028
December 24, 2025

Cerence Announces Repurchase of $30 Million of 1.50% Convertible Senior Notes Due 2028

Indeterminate GlobeNewswire
Digi Power X Provides Letter to Shareholders on 2025 Highlights and Strategic Update
December 24, 2025

Digi Power X Provides Letter to Shareholders on 2025 Highlights and Strategic Update

Indeterminate GlobeNewswire
CompoSecure, Inc. today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business combination with Husky Technologies Limited (“Husky”)
December 24, 2025

CompoSecure, Inc. today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business combination with Husky Technologies Limited (“Husky”)

Indeterminate GlobeNewswire
MuleRun Launches Creator Studio, the World’s First Platform Built for AI Agent Monetization
December 24, 2025

MuleRun Launches Creator Studio, the World’s First Platform Built for AI Agent Monetization

Indeterminate GlobeNewswire
Aussie Casino Introduces AI-Based Analysis System for iGaming Performance Evaluation
December 24, 2025

Aussie Casino Introduces AI-Based Analysis System for iGaming Performance Evaluation

Indeterminate GlobeNewswire
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
December 24, 2025

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi va acquérir Dynavax et ajouter un vaccin commercialisé contre l’hépatite B pour adultes et un candidat vaccin de phase 1⁄2 contre le zona au pipeline
December 24, 2025

Communiqué de presse : Sanofi va acquérir Dynavax et ajouter un vaccin commercialisé contre l’hépatite B pour adultes et un candidat vaccin de phase 1⁄2 contre le zona au pipeline

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente
December 24, 2025

Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente

Indeterminate GlobeNewswire
Presearch Sells Out Inaugural Node NFT Licenses in One Day
December 24, 2025

Presearch Sells Out Inaugural Node NFT Licenses in One Day

Indeterminate GlobeNewswire
ZenaTech cierra la adquisición de Vara 3D, una firma de topografía y cartografía con sede en Utah, ampliando el modelo Drones como Servicio hacia el mercado de infraestructura solar de alto crecimiento
December 24, 2025

ZenaTech cierra la adquisición de Vara 3D, una firma de topografía y cartografía con sede en Utah, ampliando el modelo Drones como Servicio hacia el mercado de infraestructura solar de alto crecimiento

Indeterminate GlobeNewswire
No Deposit Bonus Casino Canada Free Spins No Deposit By Cafe Casino
December 24, 2025

No Deposit Bonus Casino Canada Free Spins No Deposit By Cafe Casino

Indeterminate GlobeNewswire
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
December 24, 2025

U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions